Physician profile
John G Highfill
NPI 1356346548
$1,054.44
in general payments reported to CMS, 2019-2025
17 companies · $98.24 in 2025
The $98.24 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.46 · 2020: $238 · 2021: $161 · 2022: $159 · 2023: $129 · 2024: $213 · 2025: $98.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $212.22 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $198.23 | 2019-2024 | Breztri |
| Pfizer INC. | $133.25 | 2020-2025 | |
| Lilly USA, LLC | $84.32 | 2022-2024 | Mounjaro, Trulicity |
| Amgen INC. | $72.00 | 2019-2024 | Krystexxa, Repatha |
| Novo Nordisk INC | $63.28 | 2020-2025 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $56.84 | 2019-2022 | |
| Astellas Pharma US INC | $51.17 | 2023 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $29.83 | 2023-2025 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Exact Sciences Corporation | $23.44 | 2025 | Cologuard Collection Kit |
| Paratek Pharmaceuticals, INC. | $21.02 | 2021 | |
| Ibsa Pharma INC. | $20.41 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.14 | 2022 | |
| Aimmune Therapeutics, INC. | $19.19 | 2024 | |
| Novartis Pharmaceuticals Corporation | $18.67 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $16.22 | 2020 | |
| Allergan, INC. | $14.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Highfill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.